Abstract:
The present invention relates to a composition and a kit for diagnosing breast cancer, wherein microRNA or a polynucleotide which is the same as or is complementary to the fragment thereof and an integrin protein or a material specifically bonding to the fragment thereof which are contained in a vesicle are included. The present invention also relates to a method for diagnosing breast cancer using the same and obtaining information needed to diagnose breast cancer. Breast cancer can be diagnosed early in a minimally invasive manner, and patient convenience can be improved.
Abstract:
Provided is a polynucleotide for diagnosis or treatment of breast cancer, including at least 10 contiguous nucleotides of a nucleotide sequence selected from the group consisting of nucleotide sequences of SEQ ID No: 1 to SEQ ID No: 5 and comprising a nucleotide at 101st position of the nucleotide sequence, or a complementary polynucleotide thereof.
Abstract:
PURPOSE: An apparatus and method for product verification using a polynucleotide is provided to easily distinguish genuine articles and counterfeit articles. CONSTITUTION: A method for product verification comprises: a step of hybridizing a probe polynucleotide and a target polynucleotide; a step of linking the ends of a first segment and a second segment on the probe polynucleotide; a step of amplifying the probe polynucleotide; and a step of detecting the amplified product. The amplification is performed by rolling circle amplification or multiple displacement amplification. An apparatus for product verification comprises: a sample injection part(10) containing the prove polynucleotide and ligase; an amplification part(20) containing polynucleotide polymerase, primer, and dNTP; and a detection part for detecting the amplified polynucleotide.
Abstract:
A primer set is provided to amplify a resistance donating gene from antibiotics resistant bacteria. A probe set is provided to be specifically coupled to a target sequence existing in a PCR product amplified by the primer set, thereby being used for detecting at least one bacteria with the antibiotics resistance. A microarray is provided to be used for detecting the bacteria with antibiotics resistance. An oligonucleotide primer set for amplifying at least one selected from the group consisting of aataph, ant, aph, CMY1, CMY2, CTX1, CTX2, DHA, IMP, OXA, PER, SHV, TEM, VIM, ermA, ermB, ermC, mef, mecA, Spn pbp2b, Pae gyrA, Sau gyrA, Sau parC, Sau parE, vanA, and vanB is selected from the group consisting of: an oligonucleotide set including at least one oligonucleotide selected from oligonucleotides consisting of more than 10 consecutive nucleotide fragments in SEQ ID : NOs. 1 and 2; SEQ ID : NOs. 3 and 4; SEQ ID : NOs. 5 and 6; SEQ ID : NOs. 7 and 8; SEQ ID : NOs. 9 and 10; SEQ ID : NOs. 11 and 12; SEQ ID : NOs. 13 and 14; SEQ ID : NOs. 15 and 16; SEQ ID : NOs. 17 and 18; SEQ ID : NOs. 19 and 20; SEQ ID : NOs. 21 and 22; SEQ ID : NOs. 23 and 24; SEQ ID : NOs. 25 and 26; SEQ ID : NOs. 27 and 28; SEQ ID : NOs. 29 and 30; SEQ ID : NOs. 31 and 32; SEQ ID : NOs. 33 and 34; SEQ ID : NOs. 35 and 36; SEQ ID : NOs. 37 and 38; SEQ ID : NOs. 39 and 40; SEQ ID : NOs. 41 and 42; SEQ ID : NOs. 43 and 44; SEQ ID : NOs. 45 and 46; SEQ ID : NOs. 47 and 48; SEQ ID : NOs. 49 and 50; and SEQ ID : NOs. 51 and 52. A method for detecting the presence of bacteria having resistance against at least one antibiotics selected from the group consisting of aminoglycoside, beta-lactam, erythromycin, methicillin, vancomycin and quinolone-based antibiotics comprises the steps of: (a) contacting a sample with at least one oligonucleotide probe or oligonucleotide probe set to hybridize a target sequence in the sample with a probe sequence; and (b) detecting the hybridization degree between the probe and the target sequence in the sample. A kit for detecting the existence of the antibiotics resistant bacteria comprises the primer set and an instruction manual.
Abstract:
A primer set is provided to amplify a target sequence from bacteria causing 12 kinds of respiratory diseases. A probe set is provided to be specifically hybridized into the target sequence existing in a PCR product amplified by the primer set, thereby detecting at least one bacteria inducing the 12 kinds of the respiratory diseases. A detecting method is provided to detect the bacteria causing the respiratory diseases efficiently with high specificity. An oligonucleotide primer set for specifically amplifying at least one target sequence among Acinetobacter baumannii adeB gene, Bordetella pertussis Tcf gene, Chlamydophila pneumoniae Omp gene, Enterobacter aerogenes tsx gene, Enterobacter cloacae rpoS gene, Escherichia coli uspA gene, Klebsiella pneumoniae Wab gene, Legionella pneumophila Mip gene, Moraxella catarrhalis cop gene, Mycoplasma pneumoniae P1 gene, Pseudomonas aeruginosa ETA gene and Streptococcus pneumoniae lytA gene is selected from the group consisting of: an oligonucleotide set including at least one oligonucleotide selected from oligonucleotides consisting of more than 10 consecutive nucleotide fragments in SEQ ID : NOs. 1 and 2; SEQ ID : NOs. 3 and 4; SEQ ID : NOs. 5 and 6; SEQ ID : NOs. 7 and 8; SEQ ID : NOs. 9 and 10; SEQ ID : NOs. 11 and 12; SEQ ID : NOs. 13 and 14; SEQ ID : NOs. 15 and 16; SEQ ID : NOs. 17 and 18; SEQ ID : NOs. 19 and 20; SEQ ID : NOs. 21 and 22; and SEQ ID : NOs. 23 and 24. A method for detecting the presence of at least one bacteria among 12 bacteria inducing respiratory diseases consisting of Acinetobacter baumannii, Bordetella pertussis, Chlamydophila pneumoniae, Enterobacter aerogenes, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Legionella pneumophila, Moraxella catarrhalis, Mycoplasma pneumoniae, Pseudomonas aeruginosa, and Streptococcus pneumoniae comprises the steps of: (a) contacting a sample with at least one oligonucleotide probe or oligonucleotide probe set to hybridize a target sequence in the sample with a probe sequence; and (b) detecting the hybridization degree between the probe and the target sequence in the sample. A kit for detecting the existence of the 12 respiratory diseases inducing bacteria comprises the primer set and an instruction manual.
Abstract:
본 발명은 서열번호 4의 아미노산 서열을 갖고, 세포자가사 (apoptosis)를 유도하는 활성을 갖는 분리된 단백질, 및 그를 코딩하는 유전자를 제공한다. 또한, 상기 유전자 또는 그 단편이 고정화되어 있는 기판을 갖는 마이크로어레이를 제공한다. 또한, 본 발명은 상기 단백질에 특이적으로 결합하는 항체를 이용하여 유방암을 진단하는 방법 또는 세포 내에서 상기 유전자의 발현 유무를 결정하여 유방암을 진단하는 방법을 제공한다. SNP, BCRP 유전자, 유방암, 막단백질, 세포자가사
Abstract:
A myocardial infarction related single nucleotide polymorphism and a haplotype thereof are provided to be able to predict the attack probability of the myocardial infarction and genetic sensitivity, thereby being used for diagnosing the myocardial infarction and screening medicines for treating the myocardial infarction. The myocardial infarction related single nucleotide polymorphism comprises a polynucleotide including at least 8 continuous polynucleotides containing each 101th nucleotide in a polynucleotide selected from the group consisting of SEQ ID : NOs. 1-7, 9, 10 and 14, and a complimentary polynucleotide thereof. The method for identifying a subject having a modified danger degree of myocardial infarction attack comprises the steps of: (a) isolating a nucleic acid sample from the subject to de diagnosed; and (b) determining a genotype of a polymorphic site of the each 101th nucleotide in the polynucleotide selected from the group consisting of SEQ ID : NOs. 1-7, 9, 10 and 14 or a polynucleotide consisting of SEQ ID : NOs. 1-14.
Abstract translation:提供心肌梗死相关单核苷酸多态性及其单体型,以能够预测心肌梗死的发病概率和遗传敏感性,从而用于诊断心肌梗死并筛选用于治疗心肌梗死的药物。 心肌梗塞相关的单核苷酸多态性包括多核苷酸,其包含至少8个连续多核苷酸,其含有选自SEQ ID NO:1的多核苷酸中的每个第101位核苷酸。 1-7,9,10和14及其互补多核苷酸。 用于鉴定具有改变的心肌梗塞危险程度的受试者的方法包括以下步骤:(a)将来自受试者的核酸样品分离成诊断; 和(b)确定选自SEQ ID:NO的多核苷酸中的每个第101个核苷酸的多态性位点的基因型。 1-7,9,10和14或由SEQ ID NO: 1-14。
Abstract:
본 발명은 이차원상에 표시된 유전자형 데이터를 분석하는 방법 및 장치에 관한 것이다. 그 방법은 유전자형 데이터 각각에 대해 데이터를 표시하는 점과 소정의 점을 직선으로 연결하고, 연결된 직선들 중 서로 인접한 두 직선 사이의 각들을 구하는 단계; 구해진 사이각들 중 가장 큰 두개의 사이각들을 추출하는 단계; 및 추출된 두개의 사이각에 의해 세 개의 그룹(group)으로 나누어진 유전자형 데이터들을 이용하여, 표시된 유전자형 데이터들을 분석하는 단계를 포함하는 것을 특징으로 한다. 본 발명에 의하면, 실험을 통해 얻어진 유전자형 분류결과를 분석하고자하는 경우, 이차원상에 표시된 유전자형 데이터들 간에 가장 큰 두 개의 사이각을 검출하고, 검출된 사이각과 사이각에 의해 나누어진 세 개의 데이터 영역을 이용하여 유전자형 데이터를 분석함으로써, 유전자형 분류 실험 결과를 신속하고 편리하게 분석할 수 있다.